These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 380579)

  • 21. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on a novel antidepressant (viloxazin) by means of time-series analysis of TV data].
    Renfordt E; Busch H; Fähndrich E; Müller-Oerlinghausen B
    Arzneimittelforschung; 1976; 26(6):1114-6. PubMed ID: 786309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of schizophrenia without symptoms with viloxazine].
    Kornhuber HH; Lisson G; Rissotto R
    Dtsch Med Wochenschr; 1985 Apr; 110(17):698. PubMed ID: 3886343
    [No Abstract]   [Full Text] [Related]  

  • 26. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the position of viloxazin in the group of antidepressants (author's transl)].
    Náhunek K; Svestka J; Cesková E; Misurec J
    Cesk Psychiatr; 1978 Feb; 74(1):3-8. PubMed ID: 352549
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the effect of the antidepressant viloxazin on EEG and optimization of the system driver-vehicle-road (author's transl)].
    Bente D; Chenchanna P; Scheuler W; Sponagel P
    Arzneimittelforschung; 1978; 28(8):1308-10. PubMed ID: 582393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 33. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
    Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
    Dostal T; Kabes J
    Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
    [No Abstract]   [Full Text] [Related]  

  • 35. Viloxazine: assessment of potential rapid antidepressant action.
    Edwards JG
    Br Med J; 1977 Nov; 2(6098):1327. PubMed ID: 338106
    [No Abstract]   [Full Text] [Related]  

  • 36. Viloxazine in depressed women: clinical response and cardiovascular effects.
    Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the effects of the anthracene derivative danitracen (WA335-BS) and amitriptyline in depressive patients (author's transl)].
    Matussek N; Benkert O; Fidetzis K; Flach D; Hermann HU; Kaumeier S; Kindt H; Kinzler E; Rüther E; Watzka W
    Arzneimittelforschung; 1976; 26(6):1160-2. PubMed ID: 786311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.